OGTT test vs HbA1c — understanding the difference between these two key investigations is essential for anyone navigating a diabetes diagnosis or screening in the UK. Both tests assess how the body manages blood glucose, yet they work through entirely different mechanisms and are suited to distinct clinical situations. The oral glucose tolerance test (OGTT) measures the body's real-time response to a glucose load, whilst the HbA1c reflects average blood sugar levels over the preceding two to three months. This article explains how each test works, when NHS and NICE guidance recommends one over the other, and what your results mean.

What Are the OGTT and HbA1c Tests?

The OGTT is a dynamic test measuring glucose clearance after a 75 g glucose drink, whilst HbA1c is a static marker reflecting average blood glucose over the preceding two to three months via glycation of haemoglobin.

The oral glucose tolerance test (OGTT) and the HbA1c blood test are two of the most widely used investigations for diagnosing diabetes mellitus and prediabetes. Although both assess how the body manages blood glucose, they do so through fundamentally different mechanisms and are suited to different clinical situations.

The OGTT is a dynamic functional test. After an overnight fast of at least eight hours — during which the patient should have maintained their usual diet and normal physical activity in the preceding days — a baseline venous blood glucose sample is taken. The patient then drinks a standardised glucose solution containing 75 g of anhydrous glucose (as specified by the WHO and NICE). A second blood sample is drawn two hours later to measure how effectively the body has cleared the glucose load. This reflects both insulin secretion and insulin sensitivity in real time. Some patients experience mild nausea after drinking the glucose solution.

Not sure if this is normal? Chat with one of our pharmacists →

The HbA1c test, by contrast, is a static biochemical marker. Haemoglobin A1c is formed when glucose binds irreversibly to haemoglobin within red blood cells — a process called glycation. Because red blood cells survive for approximately 90–120 days, the HbA1c level reflects average blood glucose concentration over the preceding two to three months. In the UK, HbA1c is reported in mmol/mol using IFCC-standardised units, which is the primary reporting standard; a percentage figure may sometimes be displayed alongside for reference. A single venous blood sample is all that is required, with no fasting or glucose loading necessary, making it considerably more convenient for patients and clinicians alike.

How Each Test Is Used to Diagnose Diabetes in the UK

HbA1c ≥48 mmol/mol or a 2-hour OGTT glucose ≥11.1 mmol/L diagnoses type 2 diabetes; HbA1c is unsuitable for diagnosing gestational diabetes, suspected type 1 diabetes, or in children, where plasma glucose criteria apply.

In the UK, both the OGTT and HbA1c are recognised diagnostic tools for type 2 diabetes and prediabetes, in line with guidance from NICE (including NG3 and PH38), the WHO, and the NHS. The specific thresholds used are well established:

HbA1c diagnostic thresholds:

• 48 mmol/mol (6.5%) or above on two separate occasions (or once if symptomatic) indicates type 2 diabetes

• 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (sometimes called prediabetes)

• Below 42 mmol/mol is considered normal

OGTT diagnostic thresholds (venous plasma glucose):

• Fasting glucose ≥7.0 mmol/L or 2-hour glucose ≥11.1 mmol/L indicates diabetes

• Fasting glucose 6.1–6.9 mmol/L indicates impaired fasting glucose (IFG)

• 2-hour glucose 7.8–11.0 mmol/L indicates impaired glucose tolerance (IGT)

In a symptomatic patient, a random plasma glucose of ≥11.1 mmol/L is also diagnostic of diabetes and does not require a fasting or post-load measurement to confirm.

When HbA1c should not be used for diagnosis

HbA1c is not appropriate as a diagnostic test in several important groups. It should not be used to diagnose diabetes in:

• Children and young people (NICE recommends plasma glucose-based criteria in this group)

• Suspected type 1 diabetes at any age — these patients require urgent same-day clinical assessment, as the diagnosis is based on symptoms and plasma glucose, and treatment should not be delayed

• Pregnant women — physiological changes in red blood cell turnover make HbA1c unreliable during pregnancy

• People with symptoms of diabetes lasting fewer than two months — HbA1c may not yet reflect the degree of hyperglycaemia

• People taking medications that cause rapid-onset hyperglycaemia (e.g., high-dose corticosteroids, antipsychotics) where glucose levels may have risen acutely

• People with conditions affecting red blood cell lifespan or haemoglobin structure (see the Accuracy and Limitations section below)

In any of these circumstances, plasma glucose-based testing — either fasting, random, or via the OGTT — is preferred.

The OGTT is particularly important in the diagnosis of gestational diabetes mellitus (GDM). NICE guideline NG3 specifies the OGTT as the diagnostic standard during pregnancy, typically performed between 24 and 28 weeks in women with identified risk factors. The GDM diagnostic thresholds using the 75 g OGTT are: fasting plasma glucose ≥5.6 mmol/L or 2-hour plasma glucose ≥7.8 mmol/L. Outside of pregnancy, HbA1c has become the preferred first-line diagnostic test in most routine clinical settings across the NHS.

Key Differences Between the OGTT and HbA1c

The OGTT captures acute glucose handling and may detect more cases of early glucose dysregulation, whilst HbA1c is more convenient, requires no fasting, and is more reproducible for routine screening in non-pregnant adults.

Understanding the practical and clinical distinctions between these two tests helps explain why clinicians choose one over the other in specific circumstances.

Preparation and convenience:

• The OGTT requires an overnight fast, a clinic visit lasting approximately two to three hours, and two blood draws. Patients should maintain their usual diet and normal physical activity in the days beforehand.

• The HbA1c requires no fasting, can be taken at any time of day, and involves a single blood sample — making it far more accessible.

What each test measures:

• The OGTT captures acute glucose handling — how the body responds to a defined glucose challenge at a specific point in time.

• The HbA1c reflects chronic glycaemic exposure over two to three months, providing a longer-term picture of blood glucose control.

Sensitivity and detecting glucose dysregulation: Evidence from WHO reports and large cohort studies suggests the OGTT may detect more cases of impaired glucose tolerance and early diabetes than HbA1c alone, particularly in individuals with postprandial hyperglycaemia who have a near-normal fasting glucose. Conversely, HbA1c may miss some cases that the OGTT would identify, and vice versa — the two tests do not always agree, and discordant results are not uncommon.

Clinical interpretation:

• The OGTT is more sensitive for detecting glucose dysregulation in pregnancy and in people with conditions affecting red blood cell lifespan or haemoglobin variants. HbA1c should not be used to diagnose gestational diabetes (NICE NG3).

• HbA1c is more reproducible day-to-day and less affected by acute illness or recent dietary changes, making it more stable as a monitoring and screening tool in non-pregnant adults without the conditions listed above.

Which Test Does the NHS Recommend and When?

HbA1c is the NHS preferred first-line test for diagnosing type 2 diabetes in most adults; the OGTT is recommended for gestational diabetes, when HbA1c is unreliable, or when clinical suspicion persists despite a sub-threshold HbA1c.

NHS and NICE guidance provides clear direction on when each test should be used, helping clinicians select the most appropriate investigation for each patient.

HbA1c is the preferred first-line test for diagnosing type 2 diabetes and identifying non-diabetic hyperglycaemia in most adults presenting without acute symptoms, provided none of the exclusions listed above apply. It is also used routinely to monitor glycaemic control in people already diagnosed with diabetes, typically every three to six months in line with NICE NG28.

The OGTT is recommended in the following situations:

• Gestational diabetes — NICE NG3 specifies the OGTT as the diagnostic standard during pregnancy

• When HbA1c results are unreliable or uninterpretable due to haemoglobin variants, anaemia, renal disease, or recent transfusion

• When there is clinical suspicion of diabetes but HbA1c is below the diagnostic threshold

• In people with symptoms of diabetes (polyuria, polydipsia, unexplained weight loss) where fasting or random plasma glucose is borderline

• In children and young people, and in those with suspected type 1 diabetes, where plasma glucose criteria apply

• As part of research or specialist assessment of insulin secretion and resistance

Confirming the diagnosis: A single HbA1c of 48 mmol/mol or above in a symptomatic patient is sufficient for diagnosis without a repeat test. In asymptomatic individuals, a confirmatory second test is required. If two different tests are used and give discordant results — one above and one below the diagnostic threshold — NICE and WHO guidance advises repeating the test that was above the threshold to confirm the diagnosis. The result should always be interpreted alongside the full clinical picture.

Patients should always discuss their results with their GP or diabetes care team to determine the most appropriate next steps.

Accuracy, Limitations, and Factors That Affect Results

HbA1c is unreliable in haemoglobin variants, anaemia, CKD, and pregnancy; OGTT results can be affected by acute illness, certain medications, and prolonged inactivity prior to testing.

Neither test is perfect, and both can be affected by a range of physiological, pathological, and analytical factors that may lead to falsely elevated or falsely lowered results.

Factors that affect HbA1c accuracy:

• Haemoglobin variants (e.g., sickle cell trait, HbS, HbC, HbE) can interfere with some HbA1c assay methods, producing unreliable results regardless of direction

• Iron deficiency anaemia tends to falsely elevate HbA1c by reducing red blood cell turnover and prolonging glycation time

• Haemolytic anaemia tends to falsely lower HbA1c by shortening red blood cell lifespan, reducing the time available for glycation

• Chronic kidney disease (CKD) and liver disease can affect HbA1c in variable ways depending on the degree of anaemia and uraemia present

• Recent blood transfusion introduces donor red blood cells of unknown glycation status, rendering the result uninterpretable

• Pregnancy causes increased red blood cell turnover, making HbA1c unreliable for diagnosis

In any of these circumstances, the OGTT or fasting plasma glucose is preferred. UK laboratory and RCPath/IFCC guidance provides further detail on specific assay interferences.

Factors that affect OGTT accuracy:

• Acute illness, infection, or physiological stress can temporarily impair glucose tolerance, leading to a false-positive result; the test should ideally be deferred until the patient has recovered

• Prolonged inactivity or bed rest prior to the test may affect results

• Certain medications — including corticosteroids, antipsychotics, and thiazide diuretics — can raise blood glucose and affect interpretation

• Dietary carbohydrate restriction in the days before the test may impair the normal insulin response; patients should maintain their usual diet beforehand, in line with local laboratory guidance

Patients should inform their healthcare team of all current medications before either test. Although day-to-day dietary variation has little effect on HbA1c given its long-term averaging nature, sustained dietary changes over several weeks can influence it. Clinicians should always interpret results in the context of the full clinical picture.

Next Steps After Your Test Results

Normal results warrant periodic rescreening if risk factors persist; prediabetes triggers referral to the NHS Diabetes Prevention Programme, whilst a confirmed diabetes diagnosis initiates a full clinical review, lifestyle advice, and structured education under NICE NG28.

Receiving your test results can feel daunting, but understanding what they mean — and what happens next — is an important part of managing your health effectively.

If your results are within the normal range, your GP may recommend periodic rescreening if you have ongoing risk factors such as obesity, a family history of type 2 diabetes, or a history of gestational diabetes. Lifestyle measures including a balanced diet, regular physical activity, and maintaining a healthy weight remain important preventive strategies.

If your results indicate non-diabetic hyperglycaemia (prediabetes), you are likely to be referred to the NHS Diabetes Prevention Programme (NHS DPP) — a structured, evidence-based lifestyle intervention that has been shown in UK evaluations to meaningfully reduce the risk of progression to type 2 diabetes. Your GP will also review any modifiable risk factors and may arrange follow-up HbA1c testing in 6–12 months, in line with NICE PH38 guidance.

If your results confirm a diagnosis of diabetes, your GP or practice nurse will:

• Arrange a full diabetes review including blood pressure, cholesterol, kidney function, and foot assessment

• Discuss individualised lifestyle advice and, where appropriate, initiate medication such as metformin

• Refer you to a structured diabetes education programme such as DESMOND (for type 2 diabetes)

• Set up a regular monitoring schedule in line with NICE NG28 guidance

When to seek urgent medical help:

• If you develop symptoms suggesting acutely high blood glucose — such as excessive thirst, frequent urination, unexplained weight loss, or blurred vision — contact your GP promptly or call NHS 111

• If you or someone with you feels severely unwell with symptoms such as vomiting, abdominal pain, rapid breathing, drowsiness, confusion, or a smell of ketones on the breath, seek emergency care immediately (call 999 or go to A&E) — these may be signs of a serious hyperglycaemic emergency

• If type 1 diabetes is suspected — particularly in a child, young person, or adult with rapid-onset symptoms — this requires same-day urgent assessment by a clinician; do not wait for a routine appointment

• If you are pregnant and concerned about gestational diabetes risk, speak to your midwife or GP without delay

Early diagnosis and proactive management significantly improve long-term outcomes. Always discuss your individual results and care plan with a qualified healthcare professional.

Frequently Asked Questions